Biotage AB (publ) reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported sales was SEK 504 million compared to SEK 409 million a year ago. Net income was SEK 48 million compared to SEK 34 million a year ago. Basic earnings per share from continuing operations was SEK 0.6 compared to SEK 0.49 a year ago. Diluted earnings per share from continuing operations was SEK 0.6 compared to SEK 0.49 a year ago.
For the six months, sales was SEK 984 million compared to SEK 769 million a year ago. Net income was SEK 82 million compared to SEK 77 million a year ago. Basic earnings per share from continuing operations was SEK 1.02 compared to SEK 1.13 a year ago. Diluted earnings per share from continuing operations was SEK 1.02 compared to SEK 1.13 a year ago.